(Q21521430)

16288403

Antonella d'Arminio Monforte

20 August 2022

Matthias Egger

0 references

series ordinal

3

object named as

Antonella d'Arminio Monforte

author given names

Antonella

author last names

d'Arminio Monforte

1 reference

20 August 2022

14

Gerd Fätkenheuer

Gerd

Fätkenheuer

1 reference

20 August 2022

13

Schlomo Staszewski

Schlomo

Staszewski

1 reference

20 August 2022

Caroline A Sabin

2

Caroline A

Sabin

1 reference

20 August 2022

7

Francois Dabis

Francois

Dabis

1 reference

ORCID Public Data File 2021

20 August 2022

1 reference

5

Andrew N Phillips

Andrew N

Phillips

1 reference

20 August 2022

12

Amy Justice

Amy

Justice

1 reference

20 August 2022

6

M John

Gill

M John Gill

1 reference

20 August 2022

11

Sophie

Grabar

Sophie Grabar

1 reference

20 August 2022

15

Jonathan A C

Sterne

Jonathan A C Sterne

1 reference

20 August 2022

9

Ole

Kirk

Ole Kirk

1 reference

20 August 2022

8

Peter

Reiss

Peter Reiss

1 reference

20 August 2022

1

Enrico

Girardi

Enrico Girardi

1 reference

20 August 2022

Bob Hogg

4

Bob

Hogg

1 reference

16288403

Clinical Infectious Diseases

20 August 2022

language of work or name

English

0 references

publication date

15 December 2005

0 references

published in

0 references

volume

41

0 references

issue

12

0 references

page(s)

1772-1782

0 references

cites work

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

HIV and pulmonary tuberculosis: the impact goes beyond those infected with HIV.

21 January 2018

1 reference

Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection

21 January 2018

1 reference

Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy

21 January 2018

1 reference

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

21 January 2018

1 reference

Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy

21 January 2018

1 reference

Epidemiological aspects of major opportunistic infections of the respiratory tract in persons with AIDS: Europe, 1993-2000.

21 January 2018

1 reference

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

21 January 2018

1 reference

The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy

21 January 2018

1 reference

Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy

21 January 2018

1 reference

Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.

21 January 2018

1 reference

Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies

21 January 2018

1 reference

Restoration of cellular immunity against tuberculosis in patients coinfected with HIV-1 and tuberculosis with effective antiretroviral therapy: assessment by determination of CD69 expression on T cells after tuberculin stimulation

21 January 2018

1 reference

How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners

21 January 2018

1 reference

How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control.

21 January 2018

1 reference

Nitroblue Tetrazolium Test in Hodgkin Disease and Other Malignant Lymphomas

21 January 2018

1 reference

CD4 cell counts at the third month of HAART may predict clinical failure.

21 January 2018

1 reference

Initial virological and immunologic response to highly active antiretroviral therapy predicts long-term clinical outcome.

21 January 2018

1 reference

Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan

21 January 2018

1 reference

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

21 January 2018

1 reference

High incidence of tuberculin skin test conversion among HIV-infected individuals who have a favourable immunological response to highly active antiretroviral therapy

21 January 2018

1 reference

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia

21 January 2018

1 reference

Expanded European AIDS case definition

21 January 2018

1 reference

7 January 2021

Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997

1 reference

7 January 2021

Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy

1 reference

7 January 2021

Tuberculosis and the HIV epidemic: increasing annual risk of tuberculous infection in Kenya, 1986-1996

1 reference

7 January 2021

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

1 reference

7 January 2021